Related Experiment Video
Updated: Feb 10, 2026

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
Published on: February 28, 2021
A biochemical analysis demonstrates that the BRCA1 intronic variant IVS10-2A--> C is a mutation
Jessica C Keaton1, David R Nielsen, Brant C Hendrickson
1Technology Development, Myraid Genetic Laboratories, Salt Lake City, UT 84108, USA.
Abstract:
Sequence analysis of cDNA from an asymptomatic patient belonging to a high-risk breast cancer family carrying the genetic variant BRCA1 IVS10-2A-->C revealed that functional BRCA1 mRNA was derived from only one of the patient's chromosomes. The other chromosome produced an aberrant RNA splicing transcript that deleted exon 11. Analysis of the patient's genomic DNA demonstrated that the chromosome producing the non-functional mRNA carried the genotype BRCA1 IVS10-2A-->C. This transversion disrupts a highly conserved base in the consensus splice acceptor motif. These results support the conclusion that BRCA1 IVS10-2A-->C is a mutation that confers predisposition to breast and ovarian cancer.
More Related Videos
Related Concept Videos
Point and Frameshift Mutations
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Histone Variants at the Centromere
Viral Mutations
Mutation, Gene Flow, and Genetic Drift

